Histological characteristics of complement deposition in NMOSD, MOGAD and MS

被引:0
|
作者
Takai, Yoshiki [1 ,2 ]
Hametner, Simon [3 ]
Riedl, Christian [3 ]
Misu, Tatsuro [1 ]
Fujihara, Kazuo [4 ]
Hoeftberger, Romana [3 ]
机构
[1] Tohoku Univ Hosp, Neurol, Sendai, Miyagi, Japan
[2] Tohoku Univ Hosp, Pathol, Sendai, Miyagi, Japan
[3] Med Univ Vienna, Div Neuropathol & Neurochem, Dept Neurol, Vienna, Austria
[4] Fukushima Med Univ, Multiple Sclerosis Therapeut, Fukushima, Japan
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
O075/2087
引用
收藏
页码:71 / 72
页数:2
相关论文
共 50 条
  • [41] The distinction of area postrema syndrome between MOGAD and NMOSD
    Chen, Ying
    Zhangbao, Jingzi
    Xu, Junfeng
    Zhou, Lei
    Zhou, Zhiming
    Quan, Chao
    HELIYON, 2024, 10 (10)
  • [42] Mangement of NMOSD and MOGAD in sub-Saharan Africa
    Ibrahim, Etedal
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [43] Pregnancy Outcomes and Disease Course in NMOSD and MOGAD in CANOPTICS
    Chu, L.
    Rotstein, D.
    Freedman, M. S.
    Konig, A.
    Lee, L.
    Marrie, R.
    McCombe, J.
    Morrow, S.
    Parks, N.
    Smyth, P.
    Krysko, K. M.
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 240 - 240
  • [44] C3 and C4 complement levels in AQP4-IgG-positive NMOSD and in MOGAD
    Pache, Florence
    Ringelstein, Marius
    Aktas, Orhan
    Kleiter, Ingo
    Jarius, Sven
    Siebert, Nadja
    Bellmann-Strobl, Judith
    Paul, Friedemann
    Ruprecht, Klemens
    JOURNAL OF NEUROIMMUNOLOGY, 2021, 360
  • [45] Different Complement Activation Patterns Following C5 Cleavage in MOGAD and AQP4-IgG+NMOSD
    Kaneko, Kimihiko
    Kuroda, Hiroshi
    Matsumoto, Yuki
    Sakamoto, Naohiro
    Yamazaki, Naoya
    Yamamoto, Naoki
    Umezawa, Shu
    Namatame, Chihiro
    Ono, Hirohiko
    Takai, Yoshiki
    Takahashi, Toshiyuki
    Fujimori, Juichi
    Nakashima, Ichiro
    Harigaya, Yasuo
    Lassmann, Hans
    Fujihara, Kazuo
    Misu, Tatsuro
    Aoki, Masashi
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2024, 11 (05):
  • [46] Overlapping and Distinguishing Features Among MS, NMOSD, MOGAD and Other Atypical Demyelinating Syndromes of the Central Nervous System
    Gulec, Bade
    Cam, Abdulsamet
    Bilge, Ugur
    Tutuncu, Melih
    Saip, Sabahattin
    Uygunoglu, Ugur
    Siva, Aksel
    NEUROLOGY, 2023, 100 (17)
  • [47] Serum GFAP and UCHL1 in people with MOGAD and NMOSD
    Zaninovic, Ljiljana
    Adamec, Ivan
    Turcic, Ana
    Barun, Barbara
    Gabelic, Tereza
    Skoric, Magdalena Krbot
    Lapic, Ivana
    Vogrinc, Zeljka
    Habek, Mario
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 156 - 157
  • [48] Comparison of vision-related quality of life in NMOSD and MOGAD
    Gassan, Adnan A.
    Konig, Andrea
    Nisenbaum, Rosane
    Freedman, Mark S.
    Lee, Liesly
    Marrie, Ruth Ann
    Mccombe, Jennifer A.
    Micieli, Jonathan
    Morrow, Sarah A.
    Parks, Natalie E.
    Smyth, Penelope
    Rotstein, Dalia L.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2025, 97
  • [49] Distinct CSF complement activation pattern following C5 cleavage in MOGAD and AQP4-IgG+NMOSD
    Kaneko, Kimihiko
    Kuroda, Hiroshi
    Matsumoto, Yuki
    Sakamoto, Naohiro
    Yamazaki, Naoya
    Yamamoto, Naoki
    Umezawa, Shu
    Namatame, Chihiro
    Ono, Hirohiko
    Takai, Yoshiki
    Takahashi, Toshiyuki
    Fujimori, Juichi
    Nakashima, Ichiro
    Harigaya, Yasuo
    Fujihara, Kazuo
    Misu, Tatsuro
    Aoki, Masashi
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 134 - 135
  • [50] Prevalence of misdiagnosis and time to diagnosis amongst nmosd and mogad patients
    Unsworth, Mia
    Trenholm, Emily
    Jones, Eddie
    Grant, Nikisha
    Lebrocq, Laura
    Fitzmaurice, Kristie
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 652 - 652